| effect → ReceivesAction → studied | 0.75 | |
| effect → ReceivesAction → limited | 0.58 | |
| effect → ReceivesAction → discussed | 0.56 | |
| effect → ReceivesAction → reduced | 0.53 | |
| effect → ReceivesAction → felt | 0.51 | |
| effect → ReceivesAction → measured | 0.49 | |
| effect → ReceivesAction → avoided | 0.48 | |
| effect → ReceivesAction → balanced with potential benefits | 0.43 | |
| effect → ReceivesAction → associated with therapy | 0.42 | |
| effect → ReceivesAction → lived | 0.41 | |
| effect → ReceivesAction → considered important | 0.41 | |
| effect → ReceivesAction → mediated | 0.38 | |
| effect → ReceivesAction → observed | 0.37 | |
| effect → ReceivesAction → monitored | 0.36 | |
| effect → ReceivesAction → reported | 0.31 | |
| effect → ReceivesAction → associated with drug | 0.29 | |
| effect → ReceivesAction → achieved | 0.29 | |
| effect → ReceivesAction → assessed by coronary angiography | 0.29 | |
| effect → ReceivesAction → confirmed | 0.29 | |
| effect → ReceivesAction → corroborated by similar findings | 0.29 | |
| effect → ReceivesAction → desired | 0.29 | |
| effect → ReceivesAction → enhanced | 0.29 | |
| effect → ReceivesAction → expected | 0.29 | |
| effect → ReceivesAction → maintained | 0.29 | |
| effect → ReceivesAction → maintained through 26 weeks | 0.29 | |
| effect → ReceivesAction → managed | 0.29 | |
| effect → ReceivesAction → related | 0.29 | |
| effect → ReceivesAction → studied in 10 healthy subjects | 0.29 | |
| effect → ReceivesAction → understood | 0.27 | |
| effect → ReceivesAction → associated with chemotherapy | 0.25 | |
| effect → ReceivesAction → abrogated | 0.25 | |
| effect → ReceivesAction → assessed by b-mode ultrasonogra… | 0.25 | |
| effect → ReceivesAction → assessed in 4,444 patients | 0.25 | |
| effect → ReceivesAction → assessed in 4s | 0.25 | |
| effect → ReceivesAction → compared | 0.25 | |
| effect → ReceivesAction → manifested | 0.25 | |
| effect → ReceivesAction → observed in peri/postnatal toxi… | 0.25 | |
| effect → ReceivesAction → obtained | 0.25 | |
| effect → ReceivesAction → quantified | 0.25 | |
| effect → ReceivesAction → noted | 0.20 | |
| effect → ReceivesAction → detected | 0.18 | |
| effect → ReceivesAction → caused by the disease | 0.16 | |
| effect → ReceivesAction → likely to occur | 0.16 | |
| effect → ReceivesAction → seen for diabetic | 0.16 | |
| effect → ReceivesAction → seen in the 2m/kg group | 0.16 | |
| effect → ReceivesAction → detected in small clinical trial | 0.13 | |
| effect → ReceivesAction → noted at 0.2 mg/kg/day | 0.09 | |
| effect → ReceivesAction → noted at maximum recommended hu… | 0.09 | |
| effect → ReceivesAction → recorded | 0.09 | |
| effect → ReceivesAction → reported with metolazone | 0.09 |